Novartis AG Proceeds From Noncurrent Borrowings
Novartis AG (NVSEF) reported Proceeds From Noncurrent Borrowings of $6.10 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromNoncurrentBorrowings · last filed 2026-02-04
- Novartis AG proceeds from noncurrent borrowings for the quarter ending 2024-06-30 was $2.47B, a 61725.00% increase year-over-year.
- Novartis AG proceeds from noncurrent borrowings for the quarter ending 2023-06-30 was $4.00M, a 33.33% increase year-over-year.
- Novartis AG proceeds from noncurrent borrowings for the quarter ending 2022-06-30 was $3.00M.
- Novartis AG proceeds from noncurrent borrowings for the quarter ending 2018-06-30 was $91.00M, a 4450.00% increase year-over-year.
| Period end | Proceeds From Noncurrent Borrowings 3 month | Proceeds From Noncurrent Borrowings 6 month | Proceeds From Noncurrent Borrowings 12 month |
|---|---|---|---|
| 2025-12-31 | $6.10B 20-F · filed 2026-02-04 | ||
| 2024-12-31 | $6.14B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | $2.47B 6-K · filed 2025-07-17 | $2.47B 6-K · filed 2025-07-17 | |
| 2023-06-30 | $4.00M 6-K · filed 2023-07-18 | $6.00M 6-K · filed 2023-07-18 | |
| 2022-12-31 | $16.00M 20-F/A · filed 2023-05-15 | ||
| 2022-06-30 | $3.00M 6-K · filed 2023-07-18 | $6.00M 6-K · filed 2023-07-18 | |
| 2021-12-31 | $16.00M 20-F/A · filed 2023-05-15 | ||
| 2020-12-31 | $7.13B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $4.95B 6-K · filed 2021-07-21 | ||
| 2019-12-31 | $93.00M 20-F · filed 2022-02-02 | ||
| 2018-12-31 | $2.86B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $91.00M 6-K · filed 2019-07-18 | $2.86B 6-K · filed 2019-07-18 | |
| 2017-12-31 | $4.93B 20-F · filed 2020-01-29 | ||
| 2017-06-30 | $2.00M 6-K · filed 2018-07-18 | $4.93B 6-K · filed 2018-07-18 | |
| 2016-12-31 | $1.94B 20-F · filed 2019-01-30 | ||
| 2015-12-31 | $4.60B 6-K · filed 2018-01-24 |